The past 3 decades have been characterized by an exponential growth in knowledge and
advances in the clinical treatment of atrial fibrillation (AF). It is now known that AF genesis …

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is associated with
substantial morbidity, mortality, and healthcare use. Great strides have been made in stroke …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted, focusing on 2006 through October 2012 and …

Atrial fibrillation (AF) is an arrhythmia that can occur as the result of numerous different
pathophysiological processes in the atria. Some aspects of the morphological and …

Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity
and mortality. There have been significant management advances over the past 2 decades …

The natural history of atrial fibrillation (AF) is characterized by a gradual worsening with time.
The recent finding that AF itself produces changes in atrial function and structure has …

1.1. Organization of Committee and Evidence Review (UPDATED) For new or updated text,
view the 2011 Focused Update and the 2011 Update on Dabigatran. Text supporting …

Atrial fibrillation is a condition in which control of heart rhythm is taken away from the normal
sinus node pacemaker by rapid activity in different areas within the upper chambers (atria) of …

Objectives: The aim of this report was to show that the rate of cardiovascular events is
increased in patients with either subtype of primary aldosteronism (PA). Background …

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, increasing
in prevalence with age. AF is often associated with structural heart disease, although a …